Drug Combination Details
General Information of the Combination (ID: C37217) | |||||
---|---|---|---|---|---|
Name | Vancomycin NP Info | + | Cisplatin Drug Info | ||
Structure |
![]() |
+ |
![]() |
||
Disease |
Healthy individual
[ICD-11: N.A.]
|
Investigative | [1] |
Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally | ||||||
---|---|---|---|---|---|---|
α. Decreasing Adverse Drug Reaction by This Combination | ||||||
Decreasing Adverse Drug Reaction | Click to Show/Hide | |||||
Experiment 1 Reporting the Effect of This Combination | [1] | |||||
Biological
Regulation |
Reduction | Cisplatin-induced lipid peroxidation | ||||
In-vivo Model | Healthy adult male albino rats (8-10 weeks old; weighing 120-180 g) of Wistar strain were used in this study. | |||||
Experimental
Result(s) |
Vanillic acid is a potential antioxidant that reduce cisplatin nephrotoxicity and can be as a combinatorial regimen in cancer chemotherapy. |
